Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short-term illness (acute hepatitis) and a life-threatening infection called ...

The change follows a controversial recommendation from the CDC's Advisory Committee on Immunization Practices (ACIP) to no ...

A controversial Hepatitis B vaccine safety trial will go on as planned in Africa, amid concerns over its ethics and design ...

GSK will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory ...

According to the CDC, the recommended vaccines for all children will include vaccines to protect against: measles, mumps, ...

A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...

Seven prominent medical associations on Monday sued to reverse changes to the US Centers for Disease Control and Prevention’s childhood vaccine recommendations.The lawsuit was<a class="excerpt-read-mo ...

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has hit the mark in two phase 3 trials and will be filed for approval as a potential first-in-class treatment for the disease.

Kerala is facing a severe hepatitis A outbreak, with over 31,500 cases and 82 deaths reported by late December. The contagious liver infection is largely linked to contaminated groundwater, poor ...

Sanofi's acquisition of Dynavax, valued at $2.2 billion, aims to enhance its vaccine portfolio, including a promising shingles vaccine candidate, Z-1018. Z-1018 has demonstrated comparable ...

Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.

Kerala records its highest-ever Hepatitis A with 31,536 confirmed and probable cases and 82 deaths as of December 30, 2025.. Learn what’s causing the surge, symptoms to watch for, who is at risk and ...